IonOpticks

High-performance packed emitter columns | Accelerating discoveries in medical research one sample at a time
IonOpticks
Operating

IonOpticks is an innovative Australian company that develops, manufactures and distributes advanced proteomics tools for use in disease research. Our aim is to provide innovative solutions for the global proteomics research community that will enable scientists and clinicians to discover more from their samples, accelerating advances in medical research and improving treatment outcomes by delivering personalised therapies for each patient. We specialise in high-performance chromatography columns for analytical applications in liquid chromatography with mass spectrometry (LC-MS) and high-end proteomics. Our columns are manufactured using a highly reproducible method* that provides a unique ability to enhance the sensitivity of mass spectrometry sample analysis. Based in the heart of the biotechnology precinct in Melbourne and spun out of the Walter and Eliza Hall Institute (WEHI), our mission is to provide innovative solutions for proteomics that enable researchers to discover more.

Images
Taken on 2020-12
Blog Posts
6th December, 2023
IonOpticks and Newomics broaden chromatography accessibility for Agilent mass specs, with Shimadzu pending.

PRESS RELEASE Melbourne, December 7, 2023: IonOpticks, the world leader in high performance liquid c...

30th November, 2023
High-throughput and scalable single cell proteomics identifies over 5000 proteins per cell

Research by Ye et al. out of the Olsen lab published in bioRxiv, introduces groundbreaking advanceme...

27th November, 2023
PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma

A recent study by Wartewig et al. published in Nature Cancer explores the role of PD-1, an immune ch...

14th November, 2023
Unraveling ERK3’s Role: A Novel Pathway in Actin Dynamics Control Uncovered

New research from Bogucka-Janczi et al. reveals a novel role for ERK3, an atypical MAPK, in controll...

6th November, 2023
Benchmarking commonly used software suites and analysis workflows for DIA proteomics and phosphoproteomics

A recent study using IonOpticks Aurora Series Columns compares the performance of widely used softwa...

30th October, 2023
Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection

Dong et al.have discovered that Factor Xa, a blood clotting enzyme, can cleave the SARS-CoV-2 spike ...

17th October, 2023
midiaPASEF maximizes information content in data-independent acquisition proteomics

A recent study using IonOpticks Aurora Series Columns proposes midiaPASEF, a method that improves th...

4th October, 2023
Spatial single-cell mass spectrometry defines zonation of the hepatocyte proteome

Single-cell Deep Visual Proteomics (scDVP) is a groundbreaking technology that combines high-content...

2nd October, 2023
Peptide-and Protein-Level Combined Strategy for Analyzing Newly Synthesized Proteins by Integrating Tandem Orthogonal Proteolysis with Cleavable Bioorthogonal Tagging

A new study proposes a strategy for analyzing newly synthesized proteins by integrating two differen...

13th September, 2023
Revolutionizing Immunology and Oncology: Introducing IMBAS-MS, the Next-Generation Tool for Rapid and Sensitive Plasma Immunopeptide Analysis

The study presents a significant advancement in immunopeptidomics, a field that explores the peptide...

 Location
Melbourne
 Tags
#biotech
#devices
#life sciences
#research
#sci tech
 Feedback